Slider
  • For Patients and their Families

    Here you will find useful information about clinic, our doctors, booking an appointment…

    Read more

     

  • For Health Professionals

    Find out useful information about our doctors, case studies….

    Read more

  • Announcements
    • Associate Professor Andrew Chang, Dr Thomas Pham, Dr Ran Wan and Dr Thomas Hong have returned from another successful mission in Cambodia during August 2019 to help restore vision to underprivileged patients.

       

       

      Read more
    • Novel Coronavirus 2019 (COVID-19)

       

      Are you feeling unwell, have respiratory symptoms or fever?

       

      Have you BEEN IN or TRANSITED through any of the following countries in the last 14 days; Mainland China, Iran, South Korea, Italy

       

      Have you TRANSITED through any of the following countries in the last 14 days; Cambodia, Hong Kong, Indonesia, Japan, Singapore, Thailand

       

      If you meet any of these criteria, please reschedule your appointment by phone (92213755).

       

      At Sydney Retina, we are dedicated to providing our patients with essential and emergent care. We have stringent infection control procedures in place to ensure the safety of our patients and staff. These include strict hand hygiene guidelines and single use disposable equipment and supplies.

       

      In light of the current COVID-19 concerns, we would recommend that patients attending the clinic who require someone to accompany them limit this to 1 per patient. This is to reduce the number of people within the waiting room.

       

      For more information please visit

      https://www.health.nsw.gov.au/Infectious/alerts/Pages/default.aspx

      Read more
    • Associate Professor Andrew Chang Recently presented at the Global Retinal Network Program on new developments in retinal research and the multi-disciplinary approach in treating patients with retinal disease.

       

      Read more
    • Do you have dry age-related macular degeneration? You may be eligible to participate in one of our clinical trials. Please contact our research team for more information.

       

      Announces dosing of first patient in OTX-TKI phase 1 clinical trial for the treatment of wet age-related macular degeneration (AMD). 

       

      Read more
    • An orange a day keeps the macular degeneration away.

      http://www.abc.net.au/news/2018-07-18/oranges-may-reduce-macular-degeneration-risk/10002722

      Read more
    MORE FROM RESOURCE CENTRE
    • Scientific Journal Publications

      Publications

      2018 Spooner K, Mhlanga C, Hong T, Broadhead GK, Chang A, The Burden of neovacsular age-related macular degeneration:

      Read more
    • Abstracts

      Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.

      Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Broadhead GK 1 , Hong T, Chang AA.

      Read more
    • Abstracts

      Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

      Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10. Zhu M 1 , Chew

      Read more
    OUR AFFILIATES